Public procurement notice: Contract Notice
Published: 2018-03-16
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33661000
Estimated value: 14800000 GBP
Submission deadline: 2018-04-16
Award criteria: The most economic tender

Technical requirements: Framework Agreement for the supply of Glatiramer Acetate Injection in 20mg and 40mg presentations to Participating Authorities across NHS.
Supply will be made either directly to hospitals, patients in their own homes, or other designated delivery address, via a manufactured commissioned Home Delivery Service or to a home delivery supplier(s) as directed by the Participating Authorities and/or the Authority.
Glatiramer Acetate Injection including the provision of a manufacturer commissioned Home Delivery Service.
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This Lot is for the supply of 20 mg and 40 mg Glatiramer Acetate Injection direct to hospitals or direct to patients in their own home, or other designated address, via a manufacturer commissioned Home Delivery Service.
The Authority intends awarding this Lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.
The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
This lot is for the supply of 20mg and 40mg glatiramer acetate injection direct to hospitals or nominated Home Delivery supplier(s) as directed by Participating Authorities and / or the Authority.
The Authority intends awarding this lot as an unranked multi-supplier framework to a maximum of three (3) Framework Participants.
The Authority is entitled at its sole discretion to extend the Framework Agreement by further periods of up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation or EMA Marketing Authorisation that has been approved by approved by the MHRA for all tendered Medicines at the date of submission of the tender,
b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
c) All of the goods supplied under the framework agreement must be stored in and distributed from a site holding an MHRA Wholesaler Dealers Authorisation which covers POM medicines,

Eligibility requirements: Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.

Award value: 14800000